Safety of tropicamide and phenylephrine in pupillary mydriasis for cataract surgery

Sikander A. K. Lodhi,Manjula V. Ramsali,Dilip K. Kulkarni,P. Surender,Srinivasa Murty,SikanderA K. Lodhi,ManjulaV Ramsali,DilipK Kulkarni,P Surender
DOI: https://doi.org/10.4103/1319-4534.337859
2021-01-01
Saudi Journal of Ophthalmology
Abstract:PURPOSE: A prospective study to evaluate the adverse cardiovascular effects of topical phenylephrine and tropicamide used for pupillary mydriasis before cataract surgery.METHODS: A total of 517 consecutive eyes in 517 patients subjected to routine 0.8% tropicamide and 5% phenylephrine eye drops before undergoing cataract surgery (phacoemulsification and manual small-incision surgery) under local or topical anesthesia in a medical college hospital were analyzed.RESULTS: No untoward cardiovascular effects were seen. The increase in blood pressure after 0.8% tropicamide and 5% phenylephrine eye drops was statistically significant, but it was not relevant as it was within clinically permissible limits.CONCLUSION: The combination of 0.8% tropicamide and 5% phenylephrine eye drops is a safe and effective option for pupillary mydriasis before cataract surgery.
What problem does this paper attempt to address?